Stock UniverseDerived research view · source repositories remain read-only

Amicus Therapeutics, Inc. (FOLD)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
39.44
Global Rank
482
Market Cap
4.51B
Latest Close
14.49
RS Composite
19.26% · G#476

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
0.42%
3M
1.40%
6M
70.47%
1Y
101.25%
3Y
26.00%
5Y
48.01%
10Y
109.39%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 0.00 · 30-day average: 3.18M · Max drawdown over stored range: -77.34%

Research Snapshot

Relative Strength vs SPX

RS Composite19.26%
20D RS-12.09%
60D RS-1.40%
120D RS55.59%
Global RS Rank476 · 85.81% percentile
Qualified+ RS Rank192 · 84.74% percentile
Group ScopeQualified+
Primary RS Rank71 · 84.50% percentile
Snapshot Date2026-04-27

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank54 / 701
Primary Percentile92.44
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2025-12-312026-02-20634.21M561.28M32.79M-27.11M-0.0922.14M6.12M16.01M309M88.50%5.17%-4.27%3.49%2.52%293.54M392.66M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2025-12-31$-0.09-165.1x$2.057.1x$0.05279.5x$0.07202.2x

Shares Diluted: 309M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue260.886305.514329.233399.356528.295634.21
Revenue Growth (YoY)43.158%17.106%7.764%21.299%32.287%20.048%
Gross Profit229.842271.048290.634362.03475.352561.281
Operating Income-243.854-199.92-204.426-73.49434.06434.491
Free Cash Flow-236.517-206.375-170.341-76.531-37.44429.849
Free Cash Flow Per Share-0.914-0.76-0.589-0.259-0.1230.097
EPS (Diluted) GAAP-1.07-0.922769-0.818412-0.513557-0.184328-0.087915
EPS Growth
EPS Non-GAAP
Gross Margin88.1%88.719%88.276%90.653%89.979%88.501%
Operating Margin-93.471%-65.437%-62.092%-18.403%6.448%5.438%
Profit Margin-106.12%-81.98%-71.854%-37.957%-10.62%-4.275%
Free Cash Flow Margin-90.659%-67.55%-51.739%-19.164%-7.088%4.706%
Shares Outstanding (Diluted)258.8674271.422289.0572295.1645304.3805308.3638
Shares Change (YoY)7.673%4.85%6.497%2.113%3.122%1.309%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2025 Q42026-02-20185.21M85.67%15.95M8.61%1.69M0.91%0.01309.04M293.54M392.66Mprocessed
2025 Q32025-11-04169.06M88.49%34.27M20.27%17.31M10.24%0.06310.43M263.84M391.99Mprocessed
2025 Q22025-07-31154.69M90.16%-9.47M-6.12%-24.42M-15.79%-0.08308.25M231.00M391.32Mprocessed
2025 Q12025-05-01125.25M90.66%-7.95M-6.35%-21.69M-17.31%-0.07307.69M250.57M390.71Mprocessed
2024 Q42025-02-19149.71M90.09%15.97M10.67%14.74M9.85%0.05306.14M249.95M390.11Mprocessed
2024 Q32024-11-06141.52M90.62%21.66M15.30%-6.73M-4.75%-0.02304.69M249.76M389.49Mprocessed
2024 Q22024-08-08126.67M91.11%14.97M11.82%-15.70M-12.39%-0.05303.77M260.06M388.94Mprocessed
2024 Q12024-05-09110.40M87.71%-27.72M-25.11%-48.42M-43.86%-0.16302.90M239.60M388.39Mprocessed
2023 Q42024-02-28115.08M90.16%-3.69M-3.21%-33.84M-29.41%-0.11300.72M286.20M387.86Mprocessed
2023 Q32023-11-08103.50M90.39%-17.02M-16.45%-21.58M-20.85%-0.07295.76M280.30M394.07Mprocessed
2023 Q22023-08-0894.50M90.36%-18.86M-19.96%-43.23M-45.75%-0.15292.80M265.63M393.35Mprocessed
2023 Q12023-05-1086.27M91.95%-37.64M-43.63%-52.93M-61.36%-0.18291.34M267.11M392.66Mprocessed
2022 Q42023-03-0188.10M89.35%-42.33M-48.05%-55.87M-63.41%-0.19289.71M293.60M391.99Mprocessed
2022 Q32022-11-0781.69M83.55%-33.84M-41.42%-33.29M-40.75%-0.12289.22M354.70M391.32Mprocessed
2022 Q22022-08-0480.73M89.85%-60.61M-75.08%-62.16M-76.99%-0.21291.97M386.84M390.65Mprocessed
2022 Q12022-05-1078.72M90.37%-75.34M-95.71%-85.26M-1.08%-0.30288.48M411.19M389.99Mprocessed
2021 Q42022-02-2482.15M90.44%-72.15M-87.82%-83.28M-1.01%-0.29287.43M482.50M389.36Mprocessed
2021 Q32021-11-0979.55M85.30%-42.40M-53.30%-50.29M-63.23%-0.19267.46M556.96M388.72Mprocessed
2021 Q22021-08-0577.41M89.17%-38.83M-50.16%-51.23M-66.17%-0.19266.40M383.07M390.43Mprocessed
2021 Q12021-05-10n/an/a-53.05Mn/a-65.66Mn/an/an/a417.43M389.79Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.